Kinnevik leads a EUR 40 million funding round in Tandem Health, a Swedish company focused on developing AI-driven solutions for clinical workflows.

Information on the Target

Tandem Health is a Swedish healthcare infrastructure company that is at the forefront of incorporating artificial intelligence into clinical workflows. The organization is focused on developing a medical AI scribe designed to alleviate administrative burdens on healthcare providers, thereby improving efficiency and patient care. This innovative tool aims to streamline the documentation process, allowing clinicians to focus more on patient interactions rather than paperwork.

The company has demonstrated a clear vision of building a comprehensive European operating system specifically for clinical workflows, positioning itself as a leader in the healthcare tech space. With the increasing reliance on technology to solve challenges in healthcare, Tandem Health stands out as a significant player poised for growth and transformation within the industry.

Industry Overview in Sweden

The healthcare technology sector in Sweden has been rapidly evolving, driven by technological advancements and a growing demand for efficient healthcare solutions. The country boasts a robust healthcare infrastructure supported by significant governme

View Source

Similar Deals

Industrifonden Zymego

2026

Other VC Healthcare Facilities & Services (NEC) Sweden
Sciety Hälsa Hemma

2025

Other VC Hospitals, Clinics & Primary Care Services Sweden
Asahi Kasei Calliditas Therapeutics

2023

Other VC Proprietary & Advanced Pharmaceuticals Sweden
GAEU Ventures Developeration AB

2023

Other VC Medical Devices & Implants Sweden
Bonnier Capital Elypta

2022

Other VC Bio Diagnostics & Testing Sweden
Investinor Calliditas

2020

Other VC Proprietary & Advanced Pharmaceuticals Sweden

Kinnevik

invested in

Tandem Health

in 2025

in a Other VC deal

Disclosed details

Revenue: $275M

Deal Parameters
Industry
Country
Seller type

Sign Up to Dealert